Clin2
NCT04190862Possibly a fitRecruiting

Cell therapy for simple anal fistulas

Anal Fistula

Part of Digestive system clinical trials.

This Phase 1 study tests whether a donated-cell treatment (given with a minor procedure) can help heal simple anal fistulas. It mainly focuses on safety first, but may also look at how well the fistula closes.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
39 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 or older and able to give informed consent
  • You need a planned fistulotomy (a procedure to treat the fistula)
  • Your fistula should be simple: 2 or fewer drainage paths, and each path is 3 inches or shorter
  • You cannot have Crohn’s disease or ulcerative colitis (inflammatory bowel diseases)
  • You must not have an abscess, active infection signs (like fever, redness, swelling, or tenderness), or rectal/anal narrowing (stenosis)
  • You must be able to follow study visits and treatment instructions, including stopping other study drugs close to enrollment

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05974280Recruiting
Stem cell treatment for complex anal fistulas

This trial compares two types of stem cell treatments to help heal complex anal fistulas (abnormal tunnels near the anus). You may be eligible if your Crohn’s-related disease is mostly controlled and the fistula has not fully healed with standard treatments.

Nantes, Nantes
NCT06303752Recruiting· Phase 1/Phase 2
Tissue therapy for complex anal fistula

This trial tests whether a special tissue therapy can help heal complex anal fistulas that involve a large part of the sphincter muscle. It is for adults who need surgery for this condition and do not have certain other health issues.

Odense
NCT05641844Recruiting
Minimally invasive treatment for anal fistulas with a seton

This trial tests whether RD2 Ver.02 is safe and works better than a comparison treatment for treating anal fistulas using a less invasive approach. It may help people who have a seton in place and want to avoid major surgery like flap repair or LIFT.

Los Angeles, California
NCT07557134Not yet recruiting· Phase 2
Cell Injection Treatment for Perianal Fistulas

This trial tests a new cell-based treatment (E-CEL UVEC cells) injected directly into perianal fistulas—abnormal tunnels near the anus that can cause pain and drainage. The goal is to help these fistulas heal without surgery.

New York, New York
NCT06456073Recruiting· Phase 1
Cell therapy for chronic anal fissures

This trial tests a new treatment made from special cells (called E-CEL UVEC) for people with long-lasting anal fissures that haven't healed with standard treatments. The goal is to see if this cell-based therapy can reduce pain and help the fissure heal.

New York, New York
NCT07035925Recruiting
Testing a hydrogel for treating anal fistulas

This trial tests a hydrogel made from natural materials to help heal a specific type of anal fistula. It may be an option if you have a single high transsphincteric fistula with a seton in place for at least four weeks.

Lebanon, New Hampshire

Hear when a new Anal Fistula trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.